APA (7th ed.) Citation

Li, Y., Hong, Y. K., Wang, X., Pandit, H., Zheng, Q., Yu, Y., . . . Martin, R. C. (2022). Epigenetic modulation enhances immunotherapy for pancreatic ductal adenocarcinoma. Clinical & Translational Immunology, 11(12), 1. https://doi.org/10.1002/cti2.1430

Chicago Style (17th ed.) Citation

Li, Yan, et al. "Epigenetic Modulation Enhances Immunotherapy for Pancreatic Ductal Adenocarcinoma." Clinical & Translational Immunology 11, no. 12 (2022): 1. https://doi.org/10.1002/cti2.1430.

MLA (9th ed.) Citation

Li, Yan, et al. "Epigenetic Modulation Enhances Immunotherapy for Pancreatic Ductal Adenocarcinoma." Clinical & Translational Immunology, vol. 11, no. 12, 2022, p. 1, https://doi.org/10.1002/cti2.1430.